Conatus Pharmaceuticals Inc. (CNAT)

[fishhunter]

Sure, it IS obvious to you and to me and to biotech and others here. However, it obviously is not obvious to Wall Street or investors-at-large. The only thing priced into the stock is the $50mil. It is insane for CNAT to be at $4.30 today when only a year or two ago it was $6 when there was a ton more risk, years away from commercialization, no Ph2 even started, no big partner like Novartis, etc.

Even compared to $1.90 in early December, the stock is far cheaper today at $4.30 given all that is now known.

So the question is....Why haven't some very deep pockets jumped on board and bought a big percentage of the company at this current price?

I am relatively certain that if I had the money I could buy 2 or 3% of the company sub-$5. That would be about 800k shares.

The walkdown from $6 over the last several weeks was done very professionally but I still would have thought that 1 or 2 or 5 individual buyers would have bought and bought and bought until CNAT was at about $12 by the start of April. I still think it goes up significantly over the next 2 months and then pops even bigger on the trial start/Novartis signing.